Sanquin
Europe, Noord-Holland, The Netherlands, Amsterdam
Description
Sanquin provides the blood supply in the community and contribute to people's quality of life with their targeted medication services.
Investor Profile
Sanquin has backed more than 3 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Convertible Note, Series A, Seed rounds (top funding stages).
- Majority of deals are located in The Netherlands.
- Strong thematic focus on Biotechnology, Life Science, Therapeutics.
Stage Focus
- Convertible Note (33%)
- Series A (33%)
- Seed (33%)
Country Focus
- The Netherlands (100%)
Industry Focus
- Biotechnology
- Life Science
- Therapeutics
- Biopharma
- Emergency Medicine
- Pharmaceutical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
